Tri-Coast Pharmacy Recalls Amino Acid Recover Eaze Due to Sterility Concerns
Tri-Coast Pharmacy is recalling 105 vials of Amino Acid Recover Eaze because the agency cannot assure the products are sterile.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class II. According to the severity rubric, an FDA Class II recall involving a structural defect or significant risk (such as lack of sterility assurance) corresponds to a score of 4 (Severe), as it is not explicitly Class I but involves a serious potential hazard.
Plain-English summary
Tri-Coast Pharmacy is recalling 105 vials of Amino Acid Recover Eaze (50 ML) nationwide. The product contains Phenylaline (L), Tyrosine (L), and L-Taurine. The recall is being conducted because there is a lack of assurance of sterility for the affected products.
The recall includes all sterile products compounded between May 17, 2016, and November 17, 2016. Known lot codes with expiration dates are 06072016C (11/15/2016) and 08162016E (09/08/2016). The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Consumers and healthcare providers should stop using the recalled product and contact their pharmacist or the recalling firm for further instructions on returns or replacements.
The recalled product
- Product
- Amino Acid Recover Eaze (50 ML), Phenylaline (L) 8 mg/ml + Tyrosine (L) 0.45 mg/ml + L-Taurine 0.7 mg/ml. Compounded by Tri-Coast Pharmacy.
- Manufacturer
- Tri-Coast Pharmacy
- Hazard
- Affected units
- 105
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- 08162016E (09/08/2016).
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 80 recalled by Tri-Coast Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 80 products in this recall →Related recalls
Same manufacturer · Tri-Coast Pharmacy
See all →- SevereTri-Coast Pharmacy Recalls TriMix Injection Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls Sermorelin Forte Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls TriMix Injection Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls BiMix Phentolamine/Papaverine Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls Quad Mix Sterile Compounded Drug
FDA (Drugs) · 2017-01-11
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SevereWestern Drug Recalls Tri-Amino OAC Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- HighAlpha Lipoic Acid injectable vials recalled for sterility assurance failure
FDA (Drugs) · 2022-07-20
- SevereFDA Recalls Prostaglandin Tri-Mix Vials Due to Sterility Concerns
FDA (Drugs) · 2019-04-24
- SevereAnderson Compounding Pharmacy Recalls Prostaglandin Tri-Mix Vials for Sterility Concerns
FDA (Drugs) · 2019-04-24
- SevereBaxter Recalls Travasol Amino Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2013-12-25
- HighFDA Recalls Amino Blend Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2022-06-01